| Medical and Health Sciences | Lifetime | 374 | IR 1 | 99.98 |
| Biological Sciences | Lifetime | 259 | IR 1 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 13 | IR 1 | 100.00 |
| Biological Sciences | 2021-2025 | 4 | IR 1 | 99.99 |
| Materials Science | 2021-2025 | 786 | IR 19 | 98.53 |
| Molecular Medicine | Lifetime | 8 | IR 1 | 99.85 |
| Surgery | Lifetime | 264 | IR 1 | 99.77 |
| Molecular Biology | Lifetime | 549 | IR 1 | 99.73 |
| Epidemiology | Lifetime | 474 | IR 1 | 99.40 |
| Cancer Research | Lifetime | 180 | IR 1 | 99.00 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 371 | IR 2 | 98.89 |
| Complementary and Alternative Medicine | Lifetime | 281 | IR 3 | 98.61 |
| Nutrition and Dietetics | Lifetime | 362 | IR 3 | 98.41 |
| Pharmacology | Lifetime | 191 | IR 1 | 98.38 |
| Clinical Pharmacology | Lifetime | 430 | IR 1 | 98.19 |
| Plant Science | Lifetime | 897 | IR 4 | 98.45 |
| Food Science and Technology | Lifetime | 615 | IR 12 | 98.11 |
| Immunology | Lifetime | 627 | IR 2 | 98.11 |
| Oncology | Lifetime | 921 | IR 1 | 97.96 |
| Pathology and Forensic Medicine | Lifetime | 939 | IR 4 | 95.24 |
| Medical Biochemistry | Lifetime | 236 | IR 2 | 94.75 |
| Biomaterials | Lifetime | 896 | IR 26 | 91.62 |
| Clinical Biochemistry | Lifetime | 568 | IR 1 | 88.73 |
| Geriatrics and Gerontology | Lifetime | 398 | IR 1 | 88.30 |
| Biotechnology | Lifetime | 744 | IR 3 | 83.60 |
| Surgery | 2021-2025 | 16 | IR 1 | 99.90 |
| Molecular Biology | 2021-2025 | 18 | IR 2 | 99.93 |
| Molecular Medicine | 2021-2025 | 1 | IR 1 | 99.93 |
| Cancer Research | 2021-2025 | 9 | IR 2 | 99.69 |
| Epidemiology | 2021-2025 | 77 | IR 1 | 99.56 |
| Immunology | 2021-2025 | 43 | IR 3 | 99.08 |
| Pharmacology | 2021-2025 | 10 | IR 1 | 98.88 |
| Complementary and Alternative Medicine | 2021-2025 | 30 | IR 1 | 98.68 |
| Medical Physiology | 2021-2025 | 100 | IR 1 | 98.79 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 86 | IR 1 | 98.82 |
| Biomaterials | 2021-2025 | 81 | IR 7 | 97.60 |
| Infectious Diseases | 2021-2025 | 154 | IR 1 | 97.41 |
| Clinical Pharmacology | 2021-2025 | 115 | IR 1 | 96.06 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 323 | IR 2 | 96.96 |
| Oncology | 2021-2025 | 325 | IR 3 | 96.79 |
| Nutrition and Dietetics | 2021-2025 | 134 | IR 2 | 96.15 |
| Pathology and Forensic Medicine | 2021-2025 | 163 | IR 2 | 95.90 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 346 | IR 1 | 96.34 |
| Geriatrics and Gerontology | 2021-2025 | 79 | IR 1 | 92.58 |
| Neuroscience of Neurology | 2021-2025 | 172 | IR 2 | 90.61 |
| Genetics | 2021-2025 | 337 | IR 2 | 90.86 |
| Public, Environmental and Occupational Health | 2021-2025 | 885 | IR 9 | 90.98 |
| Food Science and Technology | 2021-2025 | 435 | IR 15 | 91.02 |
| Reproductive Medicine | 2021-2025 | 218 | IR 6 | 89.44 |
| Clinical Neurology | 2021-2025 | 350 | IR 1 | 88.97 |
| Rheumatology | 2021-2025 | 311 | IR 1 | 89.07 |
| Plant Science | 2021-2025 | 812 | IR 8 | 89.20 |
| Medical Biochemistry | 2021-2025 | 86 | IR 2 | 86.58 |
| Psychiatry and Mental health | 2021-2025 | 444 | IR 2 | 88.03 |
| Computational Theory and Mathematics | 2021-2025 | 396 | IR 7 | 85.50 |
| Obstetrics and Gynecology | 2021-2025 | 324 | IR 3 | 83.00 |
| Cell Biology | 2021-2025 | 211 | IR 2 | 78.89 |
| Periodontics | 2021-2025 | 219 | IR 6 | 79.67 |
| Curcumin's Biomedical Applications | Lifetime | 2 | IR 1 | 99.99 |
| Natural Antidiabetic Agents Studies | Lifetime | 6 | IR 1 | 99.85 |
| Pharmacological Effects of Natural Compounds | Lifetime | 18 | IR 2 | 99.58 |
| Lipoproteins and Cardiovascular Health | Lifetime | 24 | IR 1 | 99.83 |
| MicroRNA in disease regulation | Lifetime | 50 | IR 1 | 99.72 |
| Piperaceae Chemical and Biological Studies | Lifetime | 3 | IR 1 | 99.19 |
| Cancer, Lipids, and Metabolism | Lifetime | 50 | IR 1 | 99.73 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 3 | IR 2 | 99.62 |
| Plant chemical constituents analysis | Lifetime | 5 | IR 1 | 99.22 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 40 | IR 1 | 99.53 |
| COVID-19 Clinical Research Studies | Lifetime | 132 | IR 2 | 99.23 |
| Biochemical effects in animals | Lifetime | 60 | IR 1 | 99.23 |
| Inflammasome and immune disorders | Lifetime | 46 | IR 1 | 99.28 |
| RNA Interference and Gene Delivery | Lifetime | 170 | IR 2 | 99.41 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 87 | IR 1 | 99.49 |
| Circular RNAs in diseases | Lifetime | 84 | IR 4 | 99.22 |
| Essential Oils and Antimicrobial Activity | Lifetime | 118 | IR 1 | 99.36 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 53 | IR 1 | 99.16 |
| Retinoids in leukemia and cellular processes | Lifetime | 74 | IR 1 | 99.00 |
| Pomegranate: compositions and health benefits | Lifetime | 11 | IR 1 | 98.95 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 107 | IR 1 | 99.07 |
| Phagocytosis and Immune Regulation | Lifetime | 51 | IR 1 | 98.74 |
| Liver Disease Diagnosis and Treatment | Lifetime | 583 | IR 3 | 99.23 |
| Saffron Plant Research Studies | Lifetime | 9 | IR 5 | 98.94 |
| Natural product bioactivities and synthesis | Lifetime | 177 | IR 1 | 98.90 |
| Immune cells in cancer | Lifetime | 190 | IR 1 | 98.83 |
| Diabetes Treatment and Management | Lifetime | 290 | IR 1 | 98.86 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 27 | IR 5 | 97.24 |
| Cancer-related molecular mechanisms research | Lifetime | 649 | IR 6 | 98.13 |
| Extracellular vesicles in disease | Lifetime | 231 | IR 4 | 97.75 |
| Nanoparticle-Based Drug Delivery | Lifetime | 322 | IR 12 | 98.63 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 230 | IR 1 | 98.14 |
| Flavonoids in Medical Research | Lifetime | 35 | IR 4 | 97.64 |
| Metabolism, Diabetes, and Cancer | Lifetime | 368 | IR 1 | 98.57 |
| Phytochemicals and Antioxidant Activities | Lifetime | 463 | IR 4 | 98.59 |
| Autophagy in Disease and Therapy | Lifetime | 272 | IR 1 | 98.02 |
| Adipose Tissue and Metabolism | Lifetime | 699 | IR 1 | 98.34 |
| Microbial Metabolism and Applications | Lifetime | 115 | IR 3 | 97.63 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 351 | IR 6 | 98.73 |
| Phytochemistry and Biological Activities | Lifetime | 295 | IR 8 | 98.29 |
| Cholesterol and Lipid Metabolism | Lifetime | 171 | IR 1 | 97.92 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 109 | IR 2 | 97.47 |
| Nigella sativa pharmacological applications | Lifetime | 27 | IR 9 | 96.75 |
| Ginger and Zingiberaceae research | Lifetime | 63 | IR 1 | 96.26 |
| Nuclear Receptors and Signaling | Lifetime | 145 | IR 1 | 97.58 |
| Diet, Metabolism, and Disease | Lifetime | 563 | IR 8 | 97.36 |
| Advanced Glycation End Products research | Lifetime | 287 | IR 2 | 96.13 |
| Lipid metabolism and disorders | Lifetime | 260 | IR 2 | 97.08 |
| Long-Term Effects of COVID-19 | Lifetime | 775 | IR 11 | 95.06 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 386 | IR 6 | 96.32 |
| Pharmacology and Obesity Treatment | Lifetime | 311 | IR 1 | 96.56 |
| Cardiovascular Disease and Adiposity | Lifetime | 902 | IR 5 | 95.87 |
| Inflammatory mediators and NSAID effects | Lifetime | 868 | IR 2 | 95.68 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 61 | IR 1 | 95.48 |
| COVID-19 and healthcare impacts | Lifetime | 997 | IR 8 | 91.80 |
| Ferroptosis and cancer prognosis | Lifetime | 868 | IR 2 | 92.96 |
| Cynara cardunculus studies | Lifetime | 49 | IR 2 | 94.55 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 363 | IR 3 | 93.42 |
| Fatty Acid Research and Health | Lifetime | 970 | IR 5 | 94.63 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 613 | IR 1 | 94.30 |
| Apelin-related biomedical research | Lifetime | 298 | IR 3 | 92.52 |
| Berberine and alkaloids research | Lifetime | 222 | IR 3 | 92.39 |
| Hibiscus Plant Research Studies | Lifetime | 68 | IR 1 | 91.92 |
| Vitamin C and Antioxidants Research | Lifetime | 579 | IR 6 | 93.36 |
| Ginkgo biloba and Cashew Applications | Lifetime | 202 | IR 1 | 92.38 |
| Silymarin and Mushroom Poisoning | Lifetime | 94 | IR 3 | 91.81 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 510 | IR 2 | 91.75 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 724 | IR 4 | 89.63 |
| Medicinal Plants and Neuroprotection | Lifetime | 726 | IR 33 | 89.34 |
| COVID-19 Impact on Reproduction | Lifetime | 784 | IR 6 | 87.74 |
| Plant-based Medicinal Research | Lifetime | 836 | IR 4 | 88.36 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 320 | IR 2 | 87.20 |
| Phytochemicals and Medicinal Plants | Lifetime | 602 | IR 4 | 86.98 |
| Phytochemical and Pharmacological Studies | Lifetime | 279 | IR 22 | 85.17 |
| Calpain Protease Function and Regulation | Lifetime | 460 | IR 1 | 84.41 |
| Morinda citrifolia extract uses | Lifetime | 373 | IR 2 | 77.71 |
| Coenzyme Q10 studies and effects | Lifetime | 707 | IR 8 | 79.78 |
| Medicinal Plant Extracts Effects | Lifetime | 278 | IR 28 | 78.84 |
| Medicinal plant effects and applications | Lifetime | 800 | IR 30 | 76.42 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 971 | IR 42 | 76.92 |
| Sesame and Sesamin Research | Lifetime | 762 | IR 61 | 62.30 |
| Mangiferin and Mango Extracts | Lifetime | 503 | IR 11 | 46.59 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 2 | IR 1 | 99.61 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 4 | IR 1 | 99.89 |
| Curcumin's Biomedical Applications | 2021-2025 | 1 | IR 1 | 99.99 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 7 | IR 3 | 99.67 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 1 | IR 1 | 98.66 |
| RNA Interference and Gene Delivery | 2021-2025 | 9 | IR 1 | 99.74 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 8 | IR 1 | 99.89 |
| MicroRNA in disease regulation | 2021-2025 | 19 | IR 4 | 99.64 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 7 | IR 1 | 98.97 |
| Piperaceae Chemical and Biological Studies | 2021-2025 | 1 | IR 1 | 97.47 |
| COVID-19 Clinical Research Studies | 2021-2025 | 188 | IR 3 | 98.99 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 18 | IR 2 | 98.67 |
| Inflammasome and immune disorders | 2021-2025 | 35 | IR 1 | 97.85 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 36 | IR 2 | 96.84 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 241 | IR 2 | 98.70 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 20 | IR 1 | 96.76 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 9 | IR 1 | 96.94 |
| Antioxidant Activity and Oxidative Stress | 2021-2025 | 20 | IR 1 | 96.61 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 49 | IR 1 | 98.44 |
| Biochemical effects in animals | 2021-2025 | 25 | IR 1 | 96.84 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 17 | IR 1 | 94.86 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 73 | IR 2 | 96.19 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 73 | IR 4 | 97.56 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 147 | IR 2 | 96.81 |
| Diabetes Treatment and Management | 2021-2025 | 135 | IR 1 | 98.51 |
| Adipose Tissue and Metabolism | 2021-2025 | 126 | IR 2 | 96.11 |
| Folate and B Vitamins Research | 2021-2025 | 35 | IR 2 | 93.67 |
| Circular RNAs in diseases | 2021-2025 | 111 | IR 12 | 97.29 |
| Immune cells in cancer | 2021-2025 | 178 | IR 4 | 96.13 |
| Cancer-related molecular mechanisms research | 2021-2025 | 342 | IR 16 | 97.18 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 20 | IR 4 | 94.43 |
| Phagocytosis and Immune Regulation | 2021-2025 | 34 | IR 3 | 93.66 |
| Ginger and Zingiberaceae research | 2021-2025 | 15 | IR 3 | 92.98 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 98 | IR 2 | 96.47 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 27 | IR 1 | 94.79 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 26 | IR 1 | 95.38 |
| Immunotherapy and Immune Responses | 2021-2025 | 301 | IR 7 | 95.96 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 33 | IR 1 | 95.80 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 515 | IR 22 | 97.08 |
| COVID-19 and healthcare impacts | 2021-2025 | 365 | IR 4 | 94.13 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 46 | IR 2 | 93.77 |
| Pharmacological Effects of Medicinal Plants | 2021-2025 | 7 | IR 1 | 93.86 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 192 | IR 1 | 96.99 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 468 | IR 5 | 97.09 |
| Gut microbiota and health | 2021-2025 | 564 | IR 7 | 96.21 |
| Long-Term Effects of COVID-19 | 2021-2025 | 643 | IR 10 | 94.73 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 35 | IR 1 | 93.01 |
| Nuclear Receptors and Signaling | 2021-2025 | 27 | IR 1 | 92.41 |
| Diet and metabolism studies | 2021-2025 | 557 | IR 24 | 94.90 |
| Diet, Metabolism, and Disease | 2021-2025 | 187 | IR 8 | 94.60 |
| Pomegranate: compositions and health benefits | 2021-2025 | 19 | IR 1 | 90.60 |
| Natural product bioactivities and synthesis | 2021-2025 | 188 | IR 3 | 92.21 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 509 | IR 11 | 94.69 |
| Digestive system and related health | 2021-2025 | 59 | IR 2 | 90.19 |
| Pancreatic function and diabetes | 2021-2025 | 356 | IR 2 | 93.83 |
| Silymarin and Mushroom Poisoning | 2021-2025 | 9 | IR 3 | 88.59 |
| Dendrimers and Hyperbranched Polymers | 2021-2025 | 39 | IR 10 | 92.64 |
| Galectins and Cancer Biology | 2021-2025 | 94 | IR 4 | 90.60 |
| Saffron Plant Research Studies | 2021-2025 | 19 | IR 7 | 90.66 |
| Essential Oils and Antimicrobial Activity | 2021-2025 | 564 | IR 34 | 93.04 |
| Medicinal Plants and Neuroprotection | 2021-2025 | 120 | IR 8 | 90.62 |
| Lipid metabolism and disorders | 2021-2025 | 88 | IR 1 | 89.99 |
| Phytochemicals and Antioxidant Activities | 2021-2025 | 723 | IR 6 | 93.45 |
| Vitamin C and Antioxidants Research | 2021-2025 | 72 | IR 3 | 89.66 |
| Computational Drug Discovery Methods | 2021-2025 | 821 | IR 8 | 92.12 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 216 | IR 1 | 87.20 |
| Bacterial biofilms and quorum sensing | 2021-2025 | 348 | IR 16 | 89.55 |
| Nutritional Studies and Diet | 2021-2025 | 823 | IR 48 | 91.84 |
| COVID-19 Impact on Reproduction | 2021-2025 | 415 | IR 5 | 89.05 |
| Cell Adhesion Molecules Research | 2021-2025 | 200 | IR 3 | 86.53 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 104 | IR 8 | 87.18 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 838 | IR 4 | 90.45 |
| Cancer Mechanisms and Therapy | 2021-2025 | 245 | IR 5 | 87.68 |
| Nanoparticles: synthesis and applications | 2021-2025 | 735 | IR 37 | 90.97 |
| Adenosine and Purinergic Signaling | 2021-2025 | 144 | IR 1 | 86.74 |
| Microbial Metabolism and Applications | 2021-2025 | 118 | IR 3 | 87.37 |
| Oral Health Pathology and Treatment | 2021-2025 | 236 | IR 6 | 88.80 |
| Berberine and alkaloids research | 2021-2025 | 59 | IR 1 | 85.52 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 518 | IR 1 | 87.35 |
| Autophagy in Disease and Therapy | 2021-2025 | 607 | IR 5 | 86.52 |
| Mitochondrial Function and Pathology | 2021-2025 | 892 | IR 4 | 86.30 |
| Graphene and Nanomaterials Applications | 2021-2025 | 791 | IR 90 | 87.82 |
| Lysosomal Storage Disorders Research | 2021-2025 | 315 | IR 1 | 87.70 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 149 | IR 2 | 83.42 |
| Ovarian function and disorders | 2021-2025 | 589 | IR 20 | 88.19 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 185 | IR 6 | 83.35 |
| Cancer therapeutics and mechanisms | 2021-2025 | 356 | IR 1 | 84.31 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 897 | IR 1 | 86.99 |
| Advanced Drug Delivery Systems | 2021-2025 | 568 | IR 26 | 85.85 |
| Nutrition, Genetics, and Disease | 2021-2025 | 350 | IR 15 | 80.91 |
| Ethnobotanical and Medicinal Plants Studies | 2021-2025 | 330 | IR 5 | 83.43 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 305 | IR 1 | 81.79 |
| Pharmacology and Obesity Treatment | 2021-2025 | 267 | IR 2 | 81.31 |
| Hormonal Regulation and Hypertension | 2021-2025 | 787 | IR 3 | 81.71 |
| Advanced Glycation End Products research | 2021-2025 | 296 | IR 3 | 78.57 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 106 | IR 1 | 76.34 |
| Fatty Acid Research and Health | 2021-2025 | 537 | IR 13 | 77.33 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 547 | IR 9 | 74.46 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 434 | IR 3 | 76.37 |
| Mangiferin and Mango Extracts | 2021-2025 | 24 | IR 2 | 73.42 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 913 | IR 1 | 73.49 |
| S100 Proteins and Annexins | 2021-2025 | 485 | IR 4 | 70.99 |
| Nigella sativa pharmacological applications | 2021-2025 | 123 | IR 18 | 72.03 |
| Regulation of Appetite and Obesity | 2021-2025 | 619 | IR 8 | 72.94 |
| Chemokine receptors and signaling | 2021-2025 | 305 | IR 7 | 70.56 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 190 | IR 3 | 70.07 |
| Pediatric health and respiratory diseases | 2021-2025 | 905 | IR 11 | 71.83 |
| Phytoestrogen effects and research | 2021-2025 | 314 | IR 6 | 70.27 |
| Aluminum toxicity and tolerance in plants and animals | 2021-2025 | 534 | IR 9 | 71.89 |
| Drug-Induced Hepatotoxicity and Protection | 2021-2025 | 963 | IR 20 | 68.91 |
| Neuropeptides and Animal Physiology | 2021-2025 | 859 | IR 16 | 69.27 |
| Apelin-related biomedical research | 2021-2025 | 218 | IR 14 | 66.85 |
| Sesame and Sesamin Research | 2021-2025 | 137 | IR 18 | 67.11 |
| Dietary Effects on Health | 2021-2025 | 975 | IR 32 | 65.28 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 332 | IR 10 | 64.47 |
| Medical and Biological Ozone Research | 2021-2025 | 327 | IR 18 | 63.07 |
| Flavonoids in Medical Research | 2021-2025 | 239 | IR 19 | 60.09 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 860 | IR 1 | 62.58 |
| Potassium and Related Disorders | 2021-2025 | 768 | IR 2 | 58.70 |
| Phytochemistry and biological activity of medicinal plants | 2021-2025 | 236 | IR 3 | 56.62 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 749 | IR 4 | 58.94 |
| Thermal Regulation in Medicine | 2021-2025 | 842 | IR 2 | 57.41 |
| Oral health in cancer treatment | 2021-2025 | 848 | IR 21 | 57.77 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 816 | IR 8 | 57.31 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 932 | IR 32 | 56.02 |
| Hops Chemistry and Applications | 2021-2025 | 144 | IR 3 | 56.52 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 442 | IR 27 | 55.36 |
| Plant-based Medicinal Research | 2021-2025 | 537 | IR 5 | 53.50 |
| Herbal Medicine Research Studies | 2021-2025 | 297 | IR 21 | 51.34 |
| Synthesis and bioactivity of alkaloids | 2021-2025 | 168 | IR 9 | 49.84 |
| Phytochemical and Pharmacological Studies | 2021-2025 | 382 | IR 12 | 50.63 |
| Biotechnology and Related Fields | 2021-2025 | 245 | IR 1 | 45.64 |
| Food Science and Nutritional Studies | 2021-2025 | 402 | IR 3 | 44.40 |
| Natural Compounds in Disease Treatment | 2021-2025 | 301 | IR 5 | 35.04 |